|
Video: What is a Stock Split?
|
|
Signal Genetics is a commercial stage, molecular genetic diagnostic company focused on providing diagnostic services that help physicians make decisions concerning the care of their patients suffering from cancer. Co.'s primary diagnostic service is the Myeloma Prognostic Risk Signature (MyPRS®) test. The MyPRS® test is a microarray-based gene expression profile assay that measures the expression level of specific genes and groups of genes that are designed to predict an individual's long-term clinical outcome/prognosis, giving a basis for personalized treatment options and helping physicians classify multiple myeloma patients into either high or low risk groups. According to our SGNL split history records, SGNL has had 1 split. | |
|
SGNL (SGNL) has 1 split in our SGNL split history database. The split for SGNL took place on November 07, 2016. This was a 1 for 15 reverse split, meaning for each 15 shares of SGNL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as SGNL conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SGNL split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SGNL shares, starting with a $10,000 purchase of SGNL, presented on a split-history-adjusted basis factoring in the complete SGNL split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/07/2014 |
|
End date: |
02/13/2017 |
|
Start price/share: |
$67.50 |
|
End price/share: |
$12.30 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-81.78% |
|
Average Annual Total Return: |
-51.45% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,822.26 |
|
Years: |
2.36 |
|
|
|
Date |
Ratio |
11/07/2016 | 1 for 15 |
|
|